Example: Heart Attack

Search clinical trials for: Rivastigmine

Total 94 results

NCT02063269

Unknown status

Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles

Conditions: Alzheimer's Disease
NCT02703636

Completed

NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients.

Conditions: Mild to Moderate Alzheimer's Disease
NCT02989402

Recruiting

A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.

Conditions: Alzheimer's Disease
NCT02444637

Completed

Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD

Conditions: Alzheimer Disease; CVA (Cerebrovascular Accident)
NCT01146041

Completed

Bioequivalence Study of Rivastigmine Capsules 1.5 mg of Dr.Reddy's Under Fed Conditions

Conditions: Healthy
NCT01146067

Completed

Bioequivalence Study of Rivastigmine 1.5 mg Capsules Under Fasting Conditions

Conditions: Healthy
NCT01183806

Completed

Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients

Conditions: Alzheimer Disease
NCT01084135

Completed

Rivastigmine Study in Adolescents With Down Syndrome

Conditions: Down Syndrome
NCT00623103

Completed

Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)

Conditions: Parkinson's Disease Dementia
NCT02413554

Completed

Rivastigmine Patch Effect on the Post-operative Delirium in Patients at Risk of Dementia.

Conditions: Delirium
NCT01380288

Completed

Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine

Conditions: Alzheimer's Disease
NCT00835159

Completed

Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical Trial

Conditions: Delirium; Postoperative Cognitive Dysfunction
NCT00624663

Completed

A Double-Blind, Placebo-controlled Crossover Study of Repeat Rivastigmine Administration in Healthy Male Volunteers

Conditions: Rivastigmine Toxicity
NCT01312363

Completed

Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients

Conditions: Alzheimer's Disease
NCT01529619

Completed

Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors

Conditions: Alzheimer's Disease
NCT01073319

Completed

Rivastigmine as a Treatment for Methamphetamine Dependence

Conditions: Methamphetamine Dependence; Substance Abuse; Methamphetamine Abuse
NCT00748007

Completed

Efficacy of Rivastigmine in Patients With Down Syndrome

Conditions: Down Syndrome
NCT04189666

Completed

Rivastigmine Patch Compared to Melatonin Patch in Prevention of Postoperative Delirium

Conditions: Delirium
NCT00622713

Completed

A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)

Conditions: Alzheimer's Disease
NCT01602198

Terminated

Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients

Conditions: Mild Cognitive Disorder; Mild Cognitive Impairment
NCT01025466

Completed

Exelon Patch and Combination With Memantine Comparative Trial

Conditions: Alzheimer's Disease
NCT00561392

Completed

Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease

Conditions: Alzheimer's Disease
NCT03840837

Recruiting

Cholinergic Neurotransmission in Mobility and Cognition in Parkinson Disease

Conditions: Parkinson Disease
NCT01670526

Completed

Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI

Conditions: Traumatic Brain Injury; Cognitive Impairment
NCT00988117

Completed

The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems

Conditions: Parkinsons Disease With Dementia; Parkinsons Disease With Mild to Moderate Memory and/or Thinking Problems